Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 2 Effect of CRME on blood glucose level

From: Promising anitidiabetic potential of Cuscuta reflexa leaves methanol extract in alloxan-induced diabetic rats

Groups Blood glucose level in mg/dL
Day 0 Day 9 Day 18 Day 27 Day 36 Day 45
Group I 80.4 ± 2.3 81.0 ± 2.4 79.2 ± 3.4 85.8 ± 4.5 88.6 ± 3.4 81.2 ± 4.3
Group II 237.9 ± 7.6a** 245.2 ± 8.9a** 251.7 ± 8.1a** 248.8 ± 7.5a** 253.4 ± 8.3a** 249.7 ± 7.3a**
Group III 258.4 ± 8.4a** 209.7 ± 8.1b* 162.9 ± 8.5b** 138.5 ± 6.9b** 125.7 ± 7.4b** 105.7 ± 5.4b**
Group IV 244.1 ± 9.2a** 227.2 ± 9.7 215.7 ± 7.6b* 190.8 ± 8.2b** 165.1 ± 7.8b** 137.1 ± 5.8b**
Group V 267.2 ± 10.4a** 215.8 ± 9.9 193.9 ± 9.1b** 166.3 ± 6.7b** 145.9 ± 6.5b** 125.9 ± 6.5b**
Group VI 245.5 ± 9.5a** 198.8 ± 10.1b** 175.1 ± 8.9b** 140.6 ± 7.8b** 133.5 ± 6.4b** 109.5 ± 5.4b**
  1. All values were expressed as mean ± S.E.M (n = 6). (*) designates statistically significant difference from the respective group (**p < 0.01) whereas (η) designates statistically no significant difference from the relevant group (p > 0.05) using ANOVA, followed by Dunnett’s multiple comparison test. a = while compared with healthy control, b = while compared with diabetic control. Group I = Healthy control, Group II = Diabetic control, Group III = Diabetic control + 10 mg/kg of gliclazide, Group IV = Diabetic control + 100 mg/kg CRME, Group V = Diabetic control + 200 mg/kg CRME, Group VI = Diabetic control + 400 mg/kg CRME